Table 1:

Clinical characteristics of MuSK MG patients at the time of blood draw (N = 31).

Age (yr)	F/M	Onset-age (yr)	Disease duration (mo)	Race	ThymX	MGFA	MMT	Treatment (daily dose)
23	Female	22	13	B	No	2B	3	Pred 20 mg
48	Female	36	150	W	No	I	1	MMF 2000 mg
60	Female	45	186	B	No	2B	3	Pred 10 mg + MMF2000mg
23	Female	10	154	B	No	2A	5	MMF 1500mg
46	Female	45	14	B	No	I	3	Pred 20 mg
29	Female	20	109	B	No	0	0	None
67	Female	49	218	W	No	2A	3	MMF 2000 mg
56	Female	42	161	W	Yes	2B	2	None
65	Female	53	139	W	Yes	1	3	Pred 1.25 mg + MMF 2000 mg
63	Female	51	146	W	No	3B	23	Pred 5 mg + AZA 150 mg
64	Female	30	402	W	Yes	2B	9	MMF 500 mg
31	Female	26	58	B	Yes	3B	20	Plasma exchange
47	Female	34	157	B	No	2B	3	Pred 7.5 mg + MMF 2000 mg
23	Female	21	20	B	No	2A	2	Pred 30 mg + MMF 2000 mg
51	Male	43	94	B	No	1	1	AZA 75 mg
26	Female	17	112	Mixed	Yes	2B	2	Pred 20 mg + MMF 2500 mg
58	Female	43	187	B	Yes	2B	5	MMF 2000 mg
40	Female	34	78	B	No	2B	5	MMF 2000 mg
31	Female	20	138	W	No	0	0	None
44	Female	29	185	B	No	2B	6	Pred 10 mg
48	Female	32	184	B	No	2B	7	Pred 15 mg
66	Female	48	215	W	No	2B	4	Pred 1 mg
35	Female	33	28	B	No	3B	26	Mestinon 18mg + pred 30mg
45	Male	37	104	W	No	2B	9	None
28	Female	4	288	W	No	2A	7	Pred 7.5 mg + MMF 3000 mg
48	Female	9	476	W	No	3B	31	Plasma exchange
56	Female	36	235	B	No	2A	21	none
58	Female	44	173	B	No	3B	27	Pred 20 mg
53	Male	41	146	B	Yes	1	3	Pred 5 mg
28	Female	27	16	W	No	2B	17	MMF 2000 mg
25	Female	5	239	B	Yes	3A	4	Pred 3.8 mg

Abbreviations:AZA = azathioprine; B= black; d = day, F = female; mg = milligrams; M = male; MGFA =Myasthenia Gravis Foundation of America; MM = minimal manifestations; MMF = mycophenolate mofetil; MMT = myasthenia gravis manual muscle testing score at time of blood draw; Mo = months; Pred = predinison; ThymX = thymectomy; W = white; Yr =years.